2m 2m 2m 2m 2m 2m 2m
ALTO NEURO (ANRO)
NYSE
$21.95-$1.37 (-5.89%)
Price as of Oct 22, 2026 7:59 PM EDT- $915.1MMarket Cap
- 128.63%1-Year Change
- BiotechnologyIndustry
ALTO NEURO (ANRO)
$21.95-$1.37 (-5.89%)
ANRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $23.32 | ||
Change | -$1.09 (-4.47%) | ||
Open | $24.74 | ||
High | $25.01 | ||
Low | $23.28 | ||
Previous Close | $24.41 | ||
Volume | 663,459 | ||
30-Day Average Volume | 662,596 | ||
1-Week Change | 7.42% | ||
1-Month Change | -23.87% | ||
1-Year Change | 128.63% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 39.2M | ||
Total Assets | $254.1M | ||
Market Cap | $915.1M | ||
Enterprise Value | $690.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$27.6M | ||
Free Cash Flow | -$19.8M | ||
EBIT | -$27.1M | ||
EBITDA | -$27.0M | ||
Net Working Capital | $230.7M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -36 | ||
PEG | -2 | ||
Price/Free Cash Flow | -46 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue